4
Changes in Ownership
Avalo Therapeutics, Inc. Filed Acc 0001578563-20-000019
Chief Scientific Officer gave up 3,246 shares (to pay taxes)
From the SEC's structured data for this filing
Trades in this filing
Calias Pericles · Chief Scientific Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2019-07-16 | Shares withheld for taxes : show line 1 in the form | −3,246 | $4.90 | $15,905 | 49,216 | D |
Loading xslF345X03/primary_doc.xml…